Earnings · China A-shares
Medprin Regenerative Medical Technologies Co. Ltd. (301033) earnings
Medprin Regenerative Medical Technologies Co. Ltd. published its Q3 report on 2026-10-21: net profit +19.18% year on year, +19.09% excluding one-off items. Wave Radar's earnings-quality score is 100 of 100 (Sound). The stock moved +8.98% in the 3 trading days after the report.
- Report
- Q3 report
- Published
- 2026-10-21
- Period end
- 2026-09-30
- Net profit YoY
- +19.18%
- Excl. one-offs YoY
- +19.09%
- Net profit QoQ
- -5.70%
- Result
- Neutral
- Quality score
- 100
- Quality
- Sound
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | -3.83% | — |
| 3 days | +8.98% | — |
| 7 days | +6.90% | — |
| 14 days | +5.00% | — |
Report history
Over the last 8 reports, net profit grew year on year in 7 of them. The stock rose in the 3 trading days after 2 of 6 reports (average -1.63%).
| Report | Published | Net profit | Profit YoY | Excl. one-offs YoY | Revenue YoY | EPS | ROE | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 Q3 report | 2026-10-22 | ¥90.40M | +19.18% | +19.09% | +18.09% | 1.35 | 10.94% | +8.98% | — | — |
| 2026 interim report | 2026-08-21 | ¥56.58M | +19.62% | +17.26% | +20.30% | 0.85 | 6.90% | -9.12% | -11.89% | -6.18% |
| 2026 Q1 report | 2026-04-28 | ¥20.72M | -14.27% | -14.83% | +6.32% | 0.31 | 2.56% | -2.06% | -16.10% | -15.48% |
| 2025 annual report | 2026-04-28 | ¥113.13M | +43.47% | +54.80% | +32.46% | 1.71 | 15.22% | -2.06% | -16.10% | -15.48% |
| 2025 Q3 report | 2025-10-24 | ¥75.85M | +43.65% | +57.94% | +30.53% | 1.15 | 10.43% | +5.27% | -10.54% | -10.32% |
| 2025 interim report | 2025-08-22 | ¥47.30M | +46.03% | +66.20% | +29.28% | 0.71 | 6.56% | -4.58% | -19.80% | -27.59% |
| 2025 Q1 report | 2025-04-25 | ¥24.16M | +61.68% | +89.89% | +28.84% | 0.37 | 3.38% | -8.25% | -4.14% | -7.39% |
| 2024 annual report | 2025-04-25 | ¥78.85M | +92.90% | +82.94% | +20.61% | 1.20 | 11.95% | -8.25% | -4.14% | -7.39% |
The last 8 reports. Net profit is attributable to shareholders and year-to-date (a Q3 report covers the first nine months). Moves count trading days from the first tradeable session after publication; "30d vs index" is the excess return over CSI 300.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.